final dosage form

(10) The term “final dosage form” means, with respect to a biosimilar biological product, a finished dosage form which is approved for administration to a patient without substantial further manufacturing (such as lyophilized products before reconstitution).


21 USC § 379j-51(10)

Scoping language

For purposes of this subpart
Is this correct? or